Subcutaneous Nitroglycerin to Prevent Radial Artery Occlusion in Children

April 24, 2025 updated by: Young-Eun Jang, Seoul National University Hospital

Effect of Subcutaneous Nitroglycerin on the Prevention of Radial Artery Occlusion After Radial Artery Catheterization in Pediatric Patients - a Prospective Randomized Controlled Trial

The primary objective of the study is to evaluate the vasodilative effect of subcutaneous nitroglycerin to prevent radial arterial occlusion(RAO) after removal of the radial arterial catheter in pediatric patients. The hypothesis of this study is that subcutaneous nitroglycerin will decrease the incidence of radial arterial occlusion after radial arterial catheter removal in pediatric patients by increasing the radial artery size. This is a single-center, double-blind, randomized, placebo-controlled study comparing the effect of subcutaneous nitroglycerin and saline on radial artery cannulation and catheter removal in pediatric patients. Prior to the procedure, each patient will be randomized into either the control arm, saline, or the study arm, nitroglycerin.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

200

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

No older than 3 years (Child)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patients undergoing General anesthesia
  • Patients in the Intensive care unit
  • Arterial cannulation for hemodynamic monitoring, or multiple blood sample

Exclusion Criteria:

  • Unstable vital signs, significant arrhythmia or hypotension, Shock
  • High risk of peripheral ischemia
  • Skin disease, infection, hematoma, recent cannulation at the radial artery
  • History of anaphylaxis to nitroglycerin

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Nitroglycerin
Nitroglycerin 5mcg/kg (in 0.5cc) is subcutaneously injected before radial artery cannulation and before removal of the radial arterial catheter.
Subcutaneous nitroglycerin injection to decrease the incidence of radial arterial occlusion after arterial catheter removal in pediatric patients.
Active Comparator: Control
Normal saline (0.5cc) is subcutaneously injected before radial artery cannulation and before removal of the radial arterial catheter.
Subcutaneous normal saline injection to decrease the incidence of radial arterial occlusion after arterial catheter removal in pediatric patients.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The incidence of radial arterial occlusion (RAO) (%)
Time Frame: After removal of the radial artery catheter (up to 24 hour)
RAO is defined as no pulse oximeter wave at the index finger during compression of the ipsilateral ulnar artery.
After removal of the radial artery catheter (up to 24 hour)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
First attempt success rate (%)
Time Frame: During radial artery cannulation (up to 1 hour)
Success at the first skin puncture
During radial artery cannulation (up to 1 hour)
Size of radial artery (mm)
Time Frame: Before and after subcutaneous injection of drugs / Before and after catheterization / Before and after removal of the catheter (up to 1 hour)
Internal diameter of radial artery
Before and after subcutaneous injection of drugs / Before and after catheterization / Before and after removal of the catheter (up to 1 hour)
depth of radial artery (mm)
Time Frame: Before and after subcutaneous injection of drugs / Before and after catheterization / Before and after removal of the catheter (up to 1 hour)
depth of radial artery from the skin
Before and after subcutaneous injection of drugs / Before and after catheterization / Before and after removal of the catheter (up to 1 hour)
flow velocity of the radial artery (cm/s)
Time Frame: Before and after subcutaneous injection of drugs / Before and after catheterization / Before and after removal of the catheter (up to 1 hour)
flow velocity of the radial artery measured by Doppler ultrasound
Before and after subcutaneous injection of drugs / Before and after catheterization / Before and after removal of the catheter (up to 1 hour)
Perfusion index
Time Frame: Before and after subcutaneous injection of drugs / Before and after catheterization / Before and after removal of the catheter (up to 1 hour)
Perfusion index measured by pulse oximeter sensor at the distally located index finger of radial arterial catheterization
Before and after subcutaneous injection of drugs / Before and after catheterization / Before and after removal of the catheter (up to 1 hour)
Overall attempt (number)
Time Frame: During radial artery cannulation (up to 1 hour)
Number of attempt of radial artery cannulation
During radial artery cannulation (up to 1 hour)
Overall Procedure time (seconds)
Time Frame: During radial artery cannulation (up to 1 hour)
From ultrasound guidance, to Arterial waveform
During radial artery cannulation (up to 1 hour)
Overall success rate (%)
Time Frame: During radial artery cannulation (up to 1 hour)
Success within 2 skin puncture and within 10 minutes
During radial artery cannulation (up to 1 hour)
Incidence of posterior wall puncture (%)
Time Frame: During radial artery cannulation (up to 1 hour)
Incidence of posterior wall (transfixation technique) puncture during radial arterial catherization
During radial artery cannulation (up to 1 hour)
Number of arteries cannulated
Time Frame: During radial artery cannulation (up to 1 hour)
Number of arteries cannulated for peripheral arterial catheterization
During radial artery cannulation (up to 1 hour)
Malfunction of radial artery catheter
Time Frame: After radial artery cannulation assessed during anesthesia (per 24hour, up to 480 hour)
Invasive blood pressure monitoring, Sampling (%)
After radial artery cannulation assessed during anesthesia (per 24hour, up to 480 hour)
Complication rate
Time Frame: After radial artery cannulation assessed up to PACU, PICU stay (per 24hour, up to 480 hour)
Hematoma, Distal ischemia, Spasm accessed by ultrasound (%)
After radial artery cannulation assessed up to PACU, PICU stay (per 24hour, up to 480 hour)
Duration of radial arterial catherization
Time Frame: After radial artery cannulation assessed during anesthesia (up to 480 hour)
Duration of radial arterial catherization (hours, minutes)
After radial artery cannulation assessed during anesthesia (up to 480 hour)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Young-Eun Jang, MD, PhD, Clinical assistant professor, Department of anesthesiology and pain medicine

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 8, 2022

Primary Completion (Actual)

March 24, 2025

Study Completion (Actual)

March 24, 2025

Study Registration Dates

First Submitted

June 29, 2022

First Submitted That Met QC Criteria

June 29, 2022

First Posted (Actual)

July 5, 2022

Study Record Updates

Last Update Posted (Actual)

April 29, 2025

Last Update Submitted That Met QC Criteria

April 24, 2025

Last Verified

April 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • H-2206-070-1332

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Ischemia

Clinical Trials on Nitroglycerin

Subscribe